CPA
Cowen Prime Advisors Portfolio holdings
AUM
$290M
This Quarter Return
-18.85%
1 Year Return
+57.79%
3 Year Return
+115.61%
5 Year Return
+253.96%
10 Year Return
+968.93%
AUM
$164M
AUM Growth
+$164M
(-25%)
Cap. Flow
-$6.49M
Cap. Flow
% of AUM
-3.96%
Top 10 Holdings %
Top 10 Hldgs %
56.55%
Holding
217
New
39
Increased
29
Reduced
42
Closed
8
Top Buys
| 1 |
EGIO
Edgio, Inc. Common Stock
EGIO
|
$3.98M |
| 2 |
QUOT
Quotient Technology Inc
QUOT
|
$3.78M |
| 3 |
Research Solutions
RSSS
|
$3.68M |
| 4 |
PDF Solutions
PDFS
|
$3.4M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
$2.58M |
Top Sells
| 1 |
Light & Wonder
LNW
|
$7.9M |
| 2 |
NeoGenomics
NEO
|
$7.12M |
| 3 |
eHealth
EHTH
|
$5.84M |
| 4 |
MOBL
MobileIron, Inc.
MOBL
|
$5.56M |
| 5 |
Magnite
MGNI
|
$3.77M |
Sector Composition
| 1 | Technology | 30.4% |
| 2 | Communication Services | 19.84% |
| 3 | Healthcare | 15.69% |
| 4 | Industrials | 7.64% |
| 5 | Financials | 5.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HTGM
26
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
| $1.45M | 0.88% |
4,455,500
+2,317,600
| +108% | +$753K |
|
27
Kornit Digital
KRNT
$648M
| $1.45M | 0.88% |
58,044
-3,200
| -5% | -$79.7K |
|
|
MMP
28
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $1.27M | 0.78% |
34,800
| – | – |
|
29
PTC
PTC
$25.4B
| $1.17M | 0.71% |
19,050
-1,200
| -6% | -$73.4K |
|
30
Crown Castle
CCI
$42.3B
| $1.07M | 0.65% |
7,410
-8,725
| -54% | -$1.26M |
|
31
Enterprise Products Partners
EPD
$68.9B
| $1.06M | 0.65% |
74,080
+4,000
| +6% | +$57.2K |
|
32
JPMorgan Chase
JPM
$824B
| $1.02M | 0.62% |
11,329
| – | – |
|
33
Eventbrite
EB
$262M
| $1.02M | 0.62% |
139,250
+122,600
| +736% | +$895K |
|
34
3D Systems Corporation
DDD
$263M
| $1.02M | 0.62% |
131,700
-20,600
| -14% | -$159K |
|
35
Nephros
NEPH
$44M
| $975K | 0.6% |
+154,800
| New | +$975K |
|
36
Transact Technologies
TACT
$45M
| $951K | 0.58% |
305,810
+18,793
| +7% | +$58.4K |
|
37
MACOM Technology Solutions
MTSI
$9.69B
| $949K | 0.58% |
50,157
-10,501
| -17% | -$199K |
|
38
Apyx Medical
APYX
$71.9M
| $932K | 0.57% |
259,714
-25,700
| -9% | -$92.2K |
|
39
Analog Devices
ADI
$120B
| $843K | 0.51% |
+9,400
| New | +$843K |
|
|
RDFN
40
DELISTED
Redfin
RDFN
| $737K | 0.45% |
47,800
| – | – |
|
41
Teva Pharmaceuticals
TEVA
$21.5B
| $730K | 0.45% |
81,294
| – | – |
|
42
Neogen
NEOG
$1.24B
| $723K | 0.44% |
10,790
| – | – |
|
43
GSI Technology
GSIT
$84.7M
| $714K | 0.44% |
102,575
+202
| +0.2% | +$1.41K |
|
44
CEVA Inc
CEVA
$520M
| $646K | 0.39% |
25,921
-1,800
| -6% | -$44.9K |
|
45
DuPont de Nemours
DD
$31.6B
| $643K | 0.39% |
18,849
-38,993
| -67% | -$1.33M |
|
46
National Research Corp
NRC
$340M
| $637K | 0.39% |
14,000
| – | – |
|
47
Ligand Pharmaceuticals
LGND
$3.25B
| $633K | 0.39% |
+8,700
| New | +$633K |
|
48
Dow Inc
DOW
$17B
| $591K | 0.36% |
20,216
+6,667
| +49% | +$195K |
|
49
NVE Corp
NVEC
$307M
| $585K | 0.36% |
11,237
+100
| +0.9% | +$5.21K |
|
50
IBM
IBM
$227B
| $542K | 0.33% |
4,882
| – | – |
|